Table 1.
Patient characteristics and variables associated with PONV
| Group H0 (n = 50) | Group H1 (n = 49) | Group H2 (n = 50) | |
|---|---|---|---|
| Age (year) | 40 (20–60) | 39 (20–60) | 41 (21–58) |
| Weight (kg) | 56.9 (5.7) | 55.0 (7.9) | 54.4 (5.3) |
| Height (cm) | 158.7 (4.9) | 159.1 (5.5) | 157.3 (5.5) |
| ASA I/II | 40/10 | 41/8 | 39/11 |
| PONV or motion sickness history | 26 (52 %) | 28 (57 %) | 28 (56 %) |
| Anesthesia duration (min) | 150.3 (43.1) | 157.9 (39.4) | 156.4 (31.4) |
| Remifentanil consumption (μg) | 104.7 (36.2) | 97.2 (31.3) | 92.5 (29.2) |
| Surgical type | |||
| Lap. ovarian cystectomy | 17 (34 %) | 12 (24 %) | 13 (26 %) |
| Lap. hysterectomy | 23 (46 %) | 22 (45 %) | 26 (52 %) |
| Diagnostic laparoscopy | 5 (10 %) | 11 (22 %) | 6 (12 %) |
| Lap. myomectomy | 4 (8 %) | 3 (6 %) | 4 (8 %) |
| Lap. adhesiolysis | 1 (2 %) | 1 (2 %) | 1 (2 %) |
| PCA fentanyl consumption for 24 h (μg) | 470.1 (105.5) | 465.6 (102.6) | 467.8 (99.5) |
| Postoperative pain | |||
| 0-2 h | 4.9 (1.7) | 4.8 (1.8) | 4.6 (2.1) |
| 2-24 h | 2.2 (2.1) | 2.8 (1.6) | 2.2 (1.9) |
| Rescue analgesic requirements | 15 (30 %) | 11 (22 %) | 10 (20 %) |
Values are means (SD) or number (proportion). No statistically significant difference was observed among the groups
Group H0 = saline, H1 = haloperidol 1 mg, and H2 = haloperidol 2 mg
PONV postoperative nausea and vomiting; Lap laparoscopic; PCA patient-controlled analgesia